The 503a pharmacies will likely be able to continue to manufacture GLP-1 medications in doses different than those available from the manufacturers, or with added vitamins or other drugs even if the FDA prevails in these court cases
Instead, they target your metabolism, balancing out the insulin resistance, appetite changes, and abdominal fat storage that drive weight up
Again, considering remaining comorbidities and side effects will be essential as they could still impact function even after weight loss
The structural properties of GLP-1 agonists suggest they undergo hepatic metabolism and may not concentrate in milk, but absence of evidence is not evidence of safety in vulnerable infant populations
The apple cider vinegar works to stabilize blood sugar levels, preventing excess glucose from being stored as fat
Acknowledgments The authors would like to thank Aouatef Bellamine, for her help with study management and Suzanne Morris, at Concrete Medical Writing, LLC, for providing medical writing support (funded by Lonza)